Similar Search Results

Creating R&D Incentives for Medicines for Neglected Diseases : An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research

Müller-Langer, Frank - 2009

This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical...

Persistent link: https://www.econbiz.de/10013521260

AIDS and Aid : A Public Good Approach

Sonntag, Diana - 2010

worldwide. Todd Sandler (2001a) Health concerns are ?rmly embedded in the developing world. Conditions of poverty like …, affect the well-being of people globally. Of all the health crises originating from the developing world the HIV …

Persistent link: https://www.econbiz.de/10013521335

Leading pharmaceutical innovation : how to win the life science race

Gassmann, Oliver; Schuhmacher, Alexander; Zedtwitz, … - 2018 - Third edition

of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for … cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R … expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture …

Persistent link: https://www.econbiz.de/10012397599

Pharma-Einkauf : Qualitätsorientierte Prozesse – Rechtliche Rahmenbedingungen – Trends

Bergmann, Andreas - 2018

an den Einkauf von Fertigarzneimitteln -- Verpackungsmitteleinkauf in der Pharmaindustrie -- Einkauf von CRO …. Zahlreiche Praxisbeispiele zeigen Besonderheiten: die komplexe Struktur des Arzneimittel- und Gesundheitsmarktes entlang der … Auswirkungen auf den Einkauf in der Pharmaindustrie, z. B. Digitalisierung, Telemedizin, personalisierte Medizin, integrierte …

Persistent link: https://www.econbiz.de/10014019602

The Chemical and Pharmaceutical Industry in China : Opportunities and Threats for Foreign Companies

Festel, Gunter; Oels, Udo; Kreimeyer, Andreas; Zedtwitz, Max - 2005

Persistent link: https://www.econbiz.de/10013520463

Risk-sharing in the Pharmaceutical Industry : The Case of Out-licensing

Reepmeyer, Gerrit (contributor) - 2006

Deals with the topic of out-licensing as a novel form of risk-sharing collaborations. The phenomenon of out-licensing is illustrated by three major case studies of Novartis, Schering and Roche as well as several smaller case studies. This book applies the Nobel Prize awarded economic theory of...